(4-((3-(trifluoromethoxy)phenyl)sulfonyl)phenyl)methanamine | 1362160-59-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (4-((3-(trifluoromethoxy)phenyl)sulfonyl)phenyl)methanamine
• 英文别名: (4-(3-(Trifluoromethoxy)phenylsulfonyl)phenyl)methanamine；[4-[3-(trifluoromethoxy)phenyl]sulfonylphenyl]methanamine
• CAS: 1362160-59-5
• 化学式: C₁₄H₁₂F₃NO₃S
• 分子量: 331.315
• InChiKey: IAIRFAUYGHZTHX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  22
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  77.8
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  1H-吡唑[3,4-b]嘧啶-5-羧酸 、 (4-((3-(trifluoromethoxy)phenyl)sulfonyl)phenyl)methanamine 在 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 N,N-二异丙基乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 N-[[4-[3-(trifluoromethoxy)phenyl]sulfonylphenyl]methyl]-1H-pyrazolo[3,4-b]pyridine-5-carboxamide
  参考文献：
  名称：

  Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)

  摘要：

  Potent, 1H-pyrazolo[3,4-b]pyridine-containing inhibitors of the human nicotinamide phosphoribosyltransferase (NAMPT) enzyme were identified using structure-based design techniques. Many of these compounds exhibited nanomolar antiproliferation activities against human tumor lines in in vitro cell culture experiments, and a representative example (compound 26) demonstrated encouraging in vivo efficacy in a mouse xenograft tumor model derived from the A2780 cell line. This molecule also exhibited reduced rat retinal exposures relative to a previously studied imidazo-pyridine-containing NAMPT inhibitor. Somewhat surprisingly, compound 26 was only weakly active in vitro against mouse and monkey tumor cell lines even though it was a potent inhibitor of NAMPT enzymes derived from these species. The compound also exhibited only minimal effects on in vivo NAD levels in mice, and these changes were considerably less profound than those produced by an imidazo-pyridine-containing NAMPT inhibitor. The crystal structures of compound 26 and the corresponding PRPP-derived ribose adduct in complex with NAMPT were also obtained. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2013.08.074
• 作为产物：
  描述：

  3-(三氟甲氧基)苯硼酸 在 盐酸 、 copper diacetate 、 potassium carbonate 、 二甲基亚砜 作用下， 以 异丙醇 为溶剂， 反应 32.0h， 生成 (4-((3-(trifluoromethoxy)phenyl)sulfonyl)phenyl)methanamine
  参考文献：
  名称：

  发现有效和有效的含氰基胍的烟酰胺磷酸核糖基转移酶（Nampt）抑制剂

  摘要：

  利用含酰胺化合物（4）与烟酰胺磷酸核糖基转移酶（Nampt）蛋白的共晶体结构和分子建模，设计并发现了一种有效的新型含砜基氰基抑制剂，该抑制剂带有砜部分（5，Nampt Biochemical IC 50  ＝ 2.5nM，A2780细胞增殖IC 50  ＝ 9.7nM。SAR的进一步探索发现了另外几种具有高效能和良好微粒体稳定性的含氰基胍的化合物。其中，化合物15选择用于体内谱分析并在小鼠中证明良好的口服暴露。当在A2780卵巢肿瘤异种移植模型中口服给药时，它还表现出优异的体内抗肿瘤功效。还确定了该化合物与NAMPT蛋白复合的共晶体结构。

  DOI：

  10.1016/j.bmcl.2013.11.006

文献信息

• [EN] NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT<br/>[FR] NOUVEAUX COMPOSÉS ET COMPOSITIONS POUR L'INHIBITION DE NAMPT
  申请人：FORMA THERAPEUTICS INC

  公开号：WO2012031197A1

  公开（公告）日：2012-03-08

  The present invention relates to compounds and compositions for the inhibition of NAMPT, their synthesis, applications and antidotes. An illustrative compound of the invention is shown below:

  本发明涉及用于抑制NAMPT的化合物和组合物，以及它们的合成、应用和解毒剂。本发明的一个示例化合物如下所示：
• NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT
  申请人：Bair Kenneth W.

  公开号：US20140294805A1

  公开（公告）日：2014-10-02

  The present invention relates to compounds and compositions for the inhibition of NAMPT, their synthesis, applications and antidotes. An illustrative compound of the invention is shown below:

  本发明涉及用于抑制NAMPT的化合物和组合物，其合成，应用和解毒剂。本发明的一个示例化合物如下所示：
• Compounds and compositions for the inhibition of NAMPT
  申请人：Forma TM, LLC

  公开号：US10272072B2

  公开（公告）日：2019-04-30

  The present invention relates to compounds and compositions for the inhibition of NAMPT, their synthesis, applications and antidotes. An illustrative compound of the invention is shown below:

  本发明涉及抑制 NAMPT 的化合物和组合物、其合成、应用和解毒剂。本发明的一种说明性化合物如下所示：